Hong Kong stocks fluctuate | Colenbo Biological-B (06990.HK) rose nearly 7% in midday trading. Daiichi Sankyo withdraws HER3-DXd listing application, the company is expected to benefit significantly.

According to the Securities Times app, Colombo Bio Pharma-B (06990.HK) rose nearly 7% during trading hours, with a gain of 5.15% as of the time of reporting, reaching 322.8 Hong Kong dollars, with a trading volume of 162 million Hong Kong dollars.